1. A 42-year-old m an su ering from di use non-Hodgkin lym phom a w as in the hospital for autologous bone m arrow transplantation. W hich of the follow ing drugs should be adm inistered after...

1. A 42-year-old m an su ering from di use non-Hodgkin lym phom a w as in the hospital for autologous bone m arrow transplantation. W hich of the follow ing drugs should be adm inistered after transplantation to hasten neutrophil recovery? A. Leucovorin B. Filgrastim C. Oprelvekin D. Ondansetron E. Cyanocobalam in F. Allopurinol 2. A 65-year-old m an su ering from lung cancer was adm itted to the hospital for a cycle of chem otherapy. After com pletion of the cycle, a treatm ent w ith oprelvekin was started. The therapeutic e ect of the drug is m ost likely m ediated by activation of speci c receptors located m ainly on w hich of the follow ing cells? A. Neutrophils B. Lym phocytes C. Macrophages D. Monocytes E. Megakaryocytes F. Platelets